ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 137 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 8.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,849,000 | +47.4% | 85,043 | +17.1% | 0.00% | +50.0% |
| Q3 2016 | $1,933,000 | +20.9% | 72,626 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $1,599,000 | -14.5% | 72,530 | +13.9% | 0.00% | 0.0% |
| Q1 2016 | $1,871,000 | -9.3% | 63,694 | +1.9% | 0.00% | -33.3% |
| Q4 2015 | $2,063,000 | -8.4% | 62,485 | +0.3% | 0.00% | 0.0% |
| Q3 2015 | $2,252,000 | -11.9% | 62,314 | +9.7% | 0.00% | 0.0% |
| Q2 2015 | $2,556,000 | +175.1% | 56,809 | +87.2% | 0.00% | +200.0% |
| Q1 2015 | $929,000 | -39.0% | 30,342 | +1.2% | 0.00% | -50.0% |
| Q4 2014 | $1,524,000 | +28.2% | 29,979 | -0.3% | 0.00% | 0.0% |
| Q3 2014 | $1,189,000 | -7.7% | 30,057 | +0.5% | 0.00% | 0.0% |
| Q2 2014 | $1,288,000 | +211.9% | 29,914 | +189.7% | 0.00% | +100.0% |
| Q1 2014 | $413,000 | +49.6% | 10,326 | +2.1% | 0.00% | – |
| Q4 2013 | $276,000 | +19.0% | 10,118 | -0.0% | 0.00% | – |
| Q3 2013 | $232,000 | +44.1% | 10,123 | +11.4% | 0.00% | – |
| Q2 2013 | $161,000 | – | 9,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |